Skip to main content

Peer Review reports

From: Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5

Original Submission
2 Sep 2023 Submitted Original manuscript
5 Dec 2023 Reviewed Reviewer Report
25 Jan 2024 Reviewed Reviewer Report
16 Apr 2024 Author responded Author comments - Kyle C. Molina
Resubmission - Version 2
16 Apr 2024 Submitted Manuscript version 2
1 May 2024 Reviewed Reviewer Report
14 Jul 2024 Author responded Author comments - Kyle C. Molina
Resubmission - Version 3
14 Jul 2024 Submitted Manuscript version 3
29 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Aug 2024 Editorially accepted
8 Aug 2024 Article published 10.1186/s12879-024-09708-z

You can find further information about peer review here.

Back to article page